Another Drugmaker to Cut Insulin Costs

Novo Nordisk has announced it will begin slashing U.S. insulin prices up to 75% next year, mirroring a similar move being made by Eli Lilly earlier. The Danish drugmaker, which manufactures pre-filled pens and vials of long- and short-acting insulins, listed Levemir, Novolin, NovoLog and NovoLog Mix 70/30 as the products to see price reductions, set to take effect in January of 2024. As one example, the list price for NovoLog Mix 70/30 will drop to just over $72 from almost $290 currently. List prices are what a drugmaker initially sets for a product and what people without insurance or other benefits can end up paying.

Did you find our information helpful? 

We are always adding new information and resources and are open to suggestions for improvement. We can do even more with your contributions.

Service Areas Details:

  • Boulder County and City of Boulder
  • Central Mountains: Chaffee, Custer, Fremont, Lake
  • City and County of Denver
  • City of Aurora
  • Colorado Springs Metro area: Counties of El Paso, Park, Teller
  • Denver Metro area: Counties of Adams, Arapahoe, Broomfield, Clear Creek, Denver, Douglas, Gilpin, Jefferson
  • Eastern Plains: Counties of Cheyenne, Elbert, Kit Carson, Lincoln
  • Larimer County and City of Fort Collins
    Las Animas/ Huerfano: Counties of Huerfano, Las Animas
  • Northeast Colorado: Counties of Logan, Morgan, Phillips, Sedgwick, Washington, Yuma
  • Northwest: Counties of Garfield, Mesa, Moffat, Rio Blanco, Routt
  • Pueblo County and City of Pueblo
  • San Juan Region: Counties of Archuleta, Dolores, La Plata, Montezuma, San Juan
  • South Central Colorado: Counties of Alamosa, Conejos, Costilla, Mineral, Rio Grande, Saguache
  • Southeast Colorado: Baca, Bent, Crowley, Kiowa, Prowers, Otero
  • Summit Region: Counties of Eagle, Grand, Jackson, Pitkin, Summit
  • Weld County
  • West Central: Counties of Delta, Gunnison, Hinsdale, Montrose, Ouray, San Miguel